EMEA-002942-PIP02-20-M01 - paediatric investigation plan

Peptide derivative of glucagon-like-peptide 1 and glucagon with fatty acid side chain

Key facts

• Active Substance:
  Peptide derivative of glucagon-like-peptide 1 and glucagon with fatty acid side chain
• Therapeutic area:
  Gastroentology-Hepatology
• Decision number:
  P/0166/2023
• PIP number:
  EMEA-002942-PIP02-20-M01
• Pharmaceutical form(s):
  Solution for injection in pre-filled syringe
• Condition(s) / indication(s):
  Treatment of obesity
• Route(s) of administration:
  Subcutaneous use
• Contact for public enquiries:

  Boehringer Ingelheim International GmbH

  E-mail: [e-mail]; Tel: [phone]

• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  15/05/2023

Decision

P/0166/2023 : EMA decision of 15 May 2023 on the acceptance of a modification of an agreed paediatric investigation plan for peptide derivative of glucagon-like-peptide 1 and glucagon with fatty acid side chain (EMEA-002942-PIP02-20-M01)

Reference Number: EMA/160447/2023